FDA Inspection
IPR Pharmaceuticals, Inc.IPR Pharmaceuticals, Inc. – FDA Inspection, May 12, 2025
Record Details
This FDA Inspection record concerns IPR Pharmaceuticals, Inc., with an inspection on May 12, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f6d9d07c-e88c-4f9c-b4bd-1d4ad4e2032e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1271831
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of IPR Pharmaceuticals, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IPR Pharmaceuticals, Inc.
- FDA Inspection 1055499 - 2018-06-14
- FDA Inspection 942102 - 2015-08-26
- FDA Inspection 844409 - 2013-07-29
- FDA Inspection 701582 - 2010-12-07
- FDA Inspection 635541 - 2009-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.